Back
Amgen 10K Form
Sell
18
AMGN
Amgen
Last Price:
$281.21
Seasonality Move:
8.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-04-15 | 10K | AMGN/Amgen Annual |
| 2025-03-15 | 10K | AMGN/Amgen Annual |
| 2025-02-15 | 10K | AMGN/Amgen Annual |
| 2024-10-31 | 10Q | AMGN/Amgen Quarterly |
| 2024-08-07 | 10Q | AMGN/Amgen Quarterly |
| 2024-05-03 | 10Q | AMGN/Amgen Quarterly |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
| Annual Sales: | $33.4B |
|---|---|
| Cash Flow: | $980M |
| Price / Cash Flow: | 13.95 |
| Annual Sales: | $11.54 |
| Price / Book: | 24.36 |
Profitability
| EPS (TTM): | 10.96000 |
|---|---|
| Net Income (TTM): | $5.9B |
| Gross Margin: | $20.6B |
| Return on Equity: | 97.08% |
| Return on Assets: | 6.51% |
Amgen Earnings Forecast
Key Amgen Financial Ratios
-
The Gross Profit Margin over the past 41 years for AMGN is 61.53%.
-
The Selling, General & Administrative Expenses for AMGN have been equal to 21.23% of Gross Profit Margin.
-
The Research & Development expenses have been 17.84% of Revenue.
-
The Interest Expense is 77.14% of Operating Income.
-
The Net Earning history of AMGN is 12.24% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 26 years.
Amgen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMGN |
| CUSIP: | 031162 |
| Website: | amgen.com |
Debt
| Debt-to-Equity Ratio: | 9.24 |
|---|---|
| Current Ratio: | 1.17 |
| Quick Ratio: | 0.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 37.2 |
|---|---|
| Forward P/E Ratio: | 13.14 |